MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-20-0011206
Stanmax Laboratories Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹20.06 Cr
▲ 55% YoY
Net profit · FY 2024
₹47.33 Lakh
Net margin 2.4%
EBITDA · FY 2024
₹1.4 Cr
EBITDA margin 7%
Authorised capital
₹2.6 Cr
Registered with MCA
Paid-up capital
₹2.33 Cr
Issued & subscribed
Open charges
₹9.85 Cr
Secured borrowings
Company age
30 yrs
Est. 1996
Employees · EPFO
27
Provident fund records
About Stanmax Laboratories Private Limited
Data last updated:
Stanmax Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 02 December 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24235TG1996PTC025837. Its GSTIN is 36AACCS9025N1ZX (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2.6 Cr and a paid-up capital of ₹2.33 Cr. It is led by directors including Ghanukota Rupa and Ghanukota Sravan Kumar.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2 – 24 – 86/3/1 Laxmi Narayana Colony Uppal, Hyderabad, Telangana, India – 500039.
As per the financials filed for FY 2024, the company reported a revenue of ₹20.06 Cr, a growth of 55% compared to the previous year. For the same year it recorded a net profit of ₹47.33 Lakh (net margin 2.4%) and EBITDA of ₹1.4 Cr (EBITDA margin 7%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 25% over five years.
The company has about 27 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Stanmax Labs. As per MCA filings, the company has open charges of ₹9.85 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it.
Stanmax Laboratories Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0011206). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stanmaxlabs.com.
Company details
CIN U24235TG1996PTC025837
Registration Number 025837
Incorporation Date 02 December 1996
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0011206
CIN history
Stanmax Laboratories has one previous CIN (Corporate Identification Number): U24235AP1996PTC025837. The current CIN is U24235TG1996PTC025837, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24235TG1996PTC025837 | Current |
| U24235AP1996PTC025837 | Previous |
Recognitions & Rankings of Stanmax Laboratories
Contact details
Stanmax Laboratories Private Limited's registered office is in Hyderabad, Telangana. Its website is stanmaxlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address2 – 24 – 86/3/1 Laxmi Narayana Colony Uppal, Hyderabad, Telangana, India – 500039
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Stanmax Laboratories Private Limited, buy the company report.
Comprehensive company report
Stanmax Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Stanmax Laboratories operates one associated brand: Stanmax Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Veterinary pharmaceuticals and animal health care products for livestock, poultry, and companion animals. | stanmaxlabs.com |
Business activity
The main business activity of Stanmax Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Stanmax Laboratories Private Limited, buy the company report.
Financials of Stanmax Laboratories Private Limited
FY 2025 filings availableStanmax Laboratories Private Limited reported revenue of ₹20.06 Cr (up 55% YoY) for FY 2024.
Revenue · FY 2024
₹20.06 Cr ▲ 55%
Net profit · FY 2024
₹47.33 Lakh margin 2.4%
EBITDA · FY 2024
₹1.4 Cr margin 7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 55%
3 years · compounded
▲ 26%
5 years · compounded
▲ 25%
EBITDA CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 35%
5 years · compounded
▲ 36%
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 55% growth in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.4 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹47.33 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stanmax Laboratories Private Limited, buy the company report.
Board of directors of Stanmax Laboratories Private Limited
Stanmax Laboratories has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ghanukota Rupa | Director | 04 Apr 2007 | 19 Years 6 Months | Current |
| Ghanukota Sravan Kumar | Director | 28 Mar 2018 | 8 Years 7 Months | Current |
| Shashi Ramu Gunukota | Director | 20 Feb 2025 | 1 Years 8 Months | Current |
| Srija Ghanukota | Director | 20 Feb 2025 | 1 Years 8 Months | Current |
Auditor
Stanmax Laboratories Private Limited is audited by V.C.MOULI&CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V.C.MOULI&CO | FY 2023 | 202691 |
Shareholding
The shareholding of Stanmax Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Stanmax Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹9.85 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Mar 2025 | 101065316 | Sidbi | ₹7.5 Cr | Open | |
| 25 May 2021 | 100453191 | Axis Bank Limited | ₹1 Cr | Open | |
| 27 Nov 2015 | 10605476 | Hdfc Bank Limited | ₹50 Lakh | Open | |
| 29 Sep 2014 | 10528666 | Indusind Bank Limited | ₹55 Lakh | Open | |
| 30 Jul 2008 | 10118899 | Canara Bank | ₹30 Lakh | Open |
To see the full charge records of Stanmax Laboratories Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Stanmax Laboratories Private Limited has 2 court cases on record: 1 filed by Stanmax Laboratories, 1 filed against it. All cases are disposed.
Total cases
2
Filed by the company
1
Filed against the company
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Criminal miscellaneous application | Filed by the company against an individual | Disposed |
| High Court, TELANGANA | Writ petition | Filed against the company by Siflon Drugs and Pharmanceuticals Pvt., Ltd., and 1 other | Disposed |
To see the full case history of Stanmax Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stanmax Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Stanmax Laboratories Private Limited has a workforce of 27 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
27
Active EPFO establishments
1
Employee growth
12.5%
GST
Stanmax Laboratories has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCS9025N1ZX | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Stanmax Laboratories Private Limited, buy the company report.
Recent activity
Stanmax Laboratories Private Limited has 8 board changes on record since 2007: 4 appointments and 4 cessations. The latest: Shashi Ramu Gunukota was appointed as Director on 20 Feb 2025.
AGM
Stanmax Laboratories Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Stanmax Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Sidbi amounted to Rs. 7.50 Cr with Charge ID 101065316 was registered on 24 Mar 2025.
Appointed
Shashi Ramu Gunukota was appointed as Director.
Appointed
Srija Ghanukota was appointed as Director.
Charges
A charge with Axis Bank Limited of Rs. 1.00 Cr registered on 25 May 2021 with Charge ID 100453191 was modified on 23 Mar 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.00 Cr with Charge ID 100453191 was registered on 25 May 2021.
Ceased
Ghanukota Sravan Kumar ceased to be Additional Director.
Ceased
Dasari Sridhar ceased to be Director.
Ceased
Nyapathy Raghunandan ceased to be Director.
Appointed
Ghanukota Sravan Kumar was appointed as Director.
Ceased
Balguri Anuradha ceased to be Director.
7 earlier events are in the company report.
Frequently asked questions
Stanmax Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 02 December 1996 (30+ years old) and is registered under CIN U24235TG1996PTC025837.
Stanmax Laboratories has 4 current directors:
- Ghanukota Rupa - Director
- Ghanukota Sravan Kumar - Director
- Shashi Ramu Gunukota - Director
- Srija Ghanukota - Director
The latest financial statements of Stanmax Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Stanmax Laboratories is 36AACCS9025N1ZX, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Stanmax Laboratories is U24235TG1996PTC025837. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stanmax Laboratories has 2 court cases on record: 1 filed by the company and 1 filed against it. Most are in the district courts.
Stanmax Laboratories was incorporated on 02 December 1996, making it 30+ years old. It is registered with the Registrar of Companies, Hyderabad.
Shashi Ramu Gunukota was appointed as Director on 20 Feb 2025. Srija Ghanukota was appointed as Director on 20 Feb 2025. Ghanukota Sravan Kumar ceased to be Additional Director on 28 Sep 2018. Stanmax Laboratories has 8 board changes on record in total.
Yes, Stanmax Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0011206).
Stanmax Laboratories can be reached through the website stanmaxlabs.com. Its registered office is in Hyderabad, Telangana, India.